Active substance Sumatriptan
US Brand Imitrex, Imigran
IN Brand Suminat
Manufacturing by Intas Pharma
Strength 50mg / 100mg
Form release Blister 1 tab
Shipping time 7 – 18 days (Depending from the Country)
Availability & Order through request form
Make request

 

DescriptionDosageSide effectsInstructionsPhoto
If you are willing to buy sumatriptan (suminat) you need to know, that is a synthetic derivative of tryptamine.
Drug refers to the serotonergic group of drugs that have an anti-migraine effect.

Active ingredient sumatriptan, contained in the chemical composition of carisoprodol, refers to specific selective agonists of 5-HT1-serotonin receptors, concentrated mainly in the vessels of the brain. The drug affects several subtypes of serotonin receptors, for example, 5-HT 2-7, and thus contributes to the narrowing of the vessels of the arterial bed, the expansion of which leads to edema and causes migraines.

To stop a migraine attack for ingestion, the dose is 100 mg once; Sometimes an effective dose may be less than 100 mg; In case of resumption of an attack, repeated administration is possible, with the daily dose not exceeding 300 mg. If necessary, repeated injection at the same dose can be performed no earlier than 1 hour after the first administration.

With Horton’s syndrome you should to use injectable form of Sumatriptan.

Dermatological reactions: rashes on the skin, erythema, itching.

Other: sensation of heat, tingling, pain, pressure, or constriction in different parts of the body.

It is not intended for the prevention of migraine (introduction during the migraine aura before the onset of other symptoms may not prevent the development of a headache). Patients at risk of SSS do not begin therapy without a preliminary examination (women in the postmenopausal period, men over the age of 40, persons with risk factors for IHD). At appointment in a lactemia it is not recommended to breastfeed within 24 hours after taking sumatriptan. In patients with hypersensitivity to sulfonamides with the introduction of sumatriptan, there is an increased risk of allergic reactions (from skin manifestations to anaphylactic shock). If there is no effect on the administration of the first dose, the diagnosis should be clarified. The experience with sumatriptan in patients older than 65 years is limited (there is no significant difference in pharmacokinetics compared with younger patients).

Before appointment of buy sumatriptan, patients with a newly diagnosed migraine or atypical course should exclude other potentially dangerous neurological diseases. It should be borne in mind that in patients with migraine there is a risk of developing a stroke or transient ischemic stroke. After intranasal administration of sumatriptan, pain and a feeling of tightness in the chest may occur. Pain can be intense and radiate into the neck. If there are reasons to believe that these symptoms are a manifestation of CHD, it is necessary to conduct an appropriate examination. During the treatment period, care must be taken when driving vehicles and engaging in other potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.